Litcius/Paper detail

A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial

Raphaela Iris Lau, Qi Su, I.S. Lau, Jessica Ching, Martin C. S. Wong, Louis Ho Shing Lau, Hein M. Tun, Chris Mok, Steven Wai Ho Chau, Yee Kit Tse, Chun Pan Cheung, Moses K.T. Li, Giann T.Y. Yeung, Pui Kuan Cheong, Francis K.L. Chan, Siew C. Ng

2023The Lancet Infectious Diseases103 citationsDOIOpen Access PDF

Topics & Concepts

PlaceboCoronavirus disease 2019 (COVID-19)Double blindMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineAlternative medicineVirologyOutbreakPathologyDiseaseInfectious disease (medical specialty)Long-Term Effects of COVID-19Gut microbiota and healthTryptophan and brain disorders
A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial | Litcius